Trunome/Acrannolife Genomics Shark Tank Pitch:
Trunome is a product of Acrannolife Genomics which is an innovative company focusing on post-transplant patient care, has introduced a groundbreaking non-invasive diagnostic tool called Trunome, designed for early disease detection and monitoring using a simple blood test. This technology, the first of its kind in Asia and developed entirely in India, is protected by US patents. They have tested over 5,000 samples and impacted over 1,500 lives so far.
Trunome costs around $500 in India which converts to around ₹41,000 while their competitors cost around ₹2.5 lakhs. They have 3 world renowned doctors as their shareholders. Founders shared that their facility is also cleared by CDSCO. Company is also tying up with 5 major transplant hospitals in the states. They have contracts from 6 hospitals in India with confirmed orders.
Their revenue for FY21-22 was at ₹5 Crores and they are hoping to close FY22-23 at over ₹10 crores. Their monthly run rate for Trunome is at ₹35 Lakhs. Company’s EBITA is at around ₹10 lakh. They have raised another round just a month and half before their pitch at valuation of ₹75 Crores. They are expecting the revenue of ₹4000 Crores.
Trunome/Acrannolife Genomics Shark Tank Negotiations and Funding:
Namita thinks that this is too early and founders doesn’t have clarity and are pulling numbers out of the air. She thinks that India doesn’t have that big of a market therefore she steps out of the deal.
Peyush puts out the first offer of ₹1.5 Crores for 2% of the company. Anupam puts the second offer of ₹1.5 Crores for 1.75% of the company. Vineeta singh also comes in to offer ₹75 lakh for 1% and rest as interest free debt. Founders ask if all interested sharks can come together in the deal. Sharks offer ₹1.5 Crores for 2% of the company which founders accept without any hesitations.
Who are the founders of Trunome/Acrannolife Genomics?
Agragesh Ramani & Avinash Ramani Founded Trunome. Avinash have a scientific background and he has done his Phd in monocular biology. Agragesh has done MBA from IMT Gaziabad. Agragesh is CEO of the company.
How is Trunome/Acrannolife Genomics doing after Shark Tank India?
Our research in the company revealed that their deal with sharks did not close after the show aired. While reasons for fallout are still unknown. Despite this, Company is still in business as of December 2023. Company shared through LinkedIN that We are now the Top Biotech Startup Company in Chennai!
Source: Acrannolife Genomics linkedIn
Here are updates on other companies from Season 2 Episode 41
2 thoughts on “How is Trunome/Acrannolife doing after Shark Tank India?”